These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 3293840

  • 1. Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin.
    Steerenberg PA, Vendrik CP, de Jong WH, de Groot G, Fichtinger-Schepman AM, Scheefhals AP, Schornagel JH.
    Cancer Chemother Pharmacol; 1988; 22(1):51-7. PubMed ID: 3293840
    [Abstract] [Full Text] [Related]

  • 2. Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.
    Vendrik CP, de Jong WH, Van der Minnen AC, Fichtinger-Schepman AM, Steerenberg PA, Schornagel JH.
    Anticancer Res; 1990; 10(2A):447-52. PubMed ID: 2346318
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH, Steerenberg PA, Vos JG, Bulten EJ, Verbeek F, Kruizinga W, Ruitenberg EJ.
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [Abstract] [Full Text] [Related]

  • 4. Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.
    Steerenberg PA, Storm G, de Groot G, Claessen A, Bergers JJ, Franken MA, van Hoesel QG, Wubs KL, de Jong WH.
    Cancer Chemother Pharmacol; 1988 Oct; 21(4):299-307. PubMed ID: 3370737
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.
    Harstrick A, Casper J, Guba R, Wilke H, Poliwoda H, Schmoll HJ.
    Cancer; 1989 Mar 15; 63(6):1079-83. PubMed ID: 2645036
    [Abstract] [Full Text] [Related]

  • 6. The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.
    Russell J, Adam J, Wheldon TE, Kaye SB.
    Cancer Chemother Pharmacol; 1989 Mar 15; 23(2):111-4. PubMed ID: 2535968
    [Abstract] [Full Text] [Related]

  • 7. Comparative antitumour activity of cisplatin and two new cisplatin-analogues JM8 and JM9 in human testicular carcinoma xenografts.
    Harstrick A, Casper J, Schmoll HJ.
    Int J Androl; 1987 Feb 15; 10(1):139-45. PubMed ID: 3034790
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma.
    Cantwell BM, Franks CR, Harris AL.
    Cancer Chemother Pharmacol; 1986 Feb 15; 18(3):286-8. PubMed ID: 3542271
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
    Kobayashi H, Takemura Y, Miyachi H, Ogawa T.
    Invest New Drugs; 1991 Nov 15; 9(4):313-9. PubMed ID: 1804804
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
    Dedon PC, Borch RF.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1955-64. PubMed ID: 2954556
    [Abstract] [Full Text] [Related]

  • 11. Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.
    Müller LJ, Moorer-van Delft CM, Roubos EW, Vermorken JB, Boer HH.
    Cancer Res; 1992 Feb 15; 52(4):963-73. PubMed ID: 1737358
    [Abstract] [Full Text] [Related]

  • 12. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 13. Interaction of two second generation platinum antitumor drugs with mouse thymocytes.
    Simpkins H, Pearlman LF.
    Cancer Res; 1986 Mar 15; 46(3):1433-9. PubMed ID: 3510724
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Mar 15; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 15. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
    Skillen AW, Buamah PK, Cantwell BM, Cornell C, Hodson AW, Harris AL.
    Cancer Chemother Pharmacol; 1988 Mar 15; 22(3):228-34. PubMed ID: 3044631
    [Abstract] [Full Text] [Related]

  • 16. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM, Dijkman R, Begg AC, Dubbelman R, Floot BG, Hart AA, den Engelse L.
    Cancer Res; 1988 Oct 01; 48(19):5597-603. PubMed ID: 3046743
    [Abstract] [Full Text] [Related]

  • 17. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.
    Anticancer Res; 1996 Oct 01; 16(1):33-8. PubMed ID: 8615631
    [Abstract] [Full Text] [Related]

  • 18. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E, Hrubisko M, Ujházy V.
    Neoplasma; 1984 Oct 01; 31(6):641-7. PubMed ID: 6395026
    [Abstract] [Full Text] [Related]

  • 19. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M, Balázová E, Ujházy V.
    Neoplasma; 1984 Oct 01; 31(6):649-53. PubMed ID: 6542968
    [Abstract] [Full Text] [Related]

  • 20. Cycloplatam and oxoplatin--the new antitumor platinum compounds of the second generation.
    Presnov MA, Konovalova AL.
    Arch Geschwulstforsch; 1988 Oct 01; 58(1):43-9. PubMed ID: 3285804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.